Jaguar Health Inc. (JAGX)
Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
Jaguar Health Granted Extension Until May 15, 2026, to Demonstrate Compliance with Nasdaq's Bid Price Rule; Company Announces Reverse Stock Split
📉 **NEGATIVE** • Medium confidence analysis (74%) • Mild negative signal • Limited downside risk **Sentiment:** Negative (5%) **Content type:** General